期刊文献+

硫酸镁治疗妊娠高血压综合征的群体药动学一药效学 被引量:3

POPULATION PHARMACOKINETICS/PHARMACODYNAMICS OFMAGNESIUM SULFATE IN PREGNANCY INDUCED HYPEKTENSIVE GKAVIDAS TREATED WITH THE DRUG
下载PDF
导出
摘要 用NoNMEM程序分析硫酸镁治疗妊娠高血压综合征患者的群体药动学-药效学,以快-慢速率相继静脉输注二室开放模型拟合60例患者的群体药动学参数,以效应室与中央室连接的三室模型,用参数法拟合26例患者的SigmofdE_(max)药效学模型的群体参数。采用分光光度法测定血镁浓度(以给药前的基础值作调整),选择舒张压降低的百分率为药效指标。硫酸镁的群体药动学参数为:群体典型值K_(10)(h ̄(-1)),K_(12)(h ̄(-1)),K_(21)(h ̄(-1))和Vc(L)分别等于1.62,20.8,2.70,27.0,其个体间变异σ_(K10)(%),σ_(K12)(%),σ_(K21)(%),σ_(Vc)(%)分别等于25.70,14.13,24.33,34.04,浓度的残差变异σ_E(%)等于15.03。硫酸镁的群体药效学参数为:群体典型值E_(max)(%),C_(e(50))(μg·ml ̄(-1)),v,K_(eo)(h ̄(-1))分别等于28.73,28.39,4.22,0.43。其个体间变异σ_(Emax)(%),σ_(Ce(50))(%),σ_v(%),σ_(Keo)(%)分别等于56.32,62? NONMEM program was applied for analyzing population pharmacoki netics/pharmacodynamics of magnesium sulfate in pregnancy induced hypertensive patients treated with thedrug.A 2-compartment Open medel with fast and slow consecutive intravenous infusion was used toestimate population pharmacokinetics from 60 patients,A 3-compartment model comprised an effectcompartment linked to the central compartment,sigmoid Emax effect model and parametric methedwere used to estimate population pharmacodynamic parameters from 26 patients. Serum magnesiumconcen trati on was determined by spectr ophotometric method ant it was adjusted with basic valuedetermined before dosage. The diastolic blood pressure lowering effect was chosen as index of effect ofcardiovascular response.The population pharmacokinetic parameters of magnesium sulfate were:the standard value ofK_(10)(h ̄(-1)),K_(12)(h ̄(-1)),K_(21)(h ̄(-1)),and Vc(L·kg ̄(-1))were estimated to be l.62,20.8,2.70,and27.0 , respectively.Their interindividual varibilities were estimated to be 25.70%,14.13%,24.33%,and 34.04%,respectively.The residual error of concentrations was 15.03%,Thepopulation pharmacedynamic parameters of magnesium sulfate were:the standard value of E_(max)(%),Ce_(50)(μ· ml ̄(-1)),v,and K_(eo)(h ̄(-1))were estimated to be 28.73,28.39,4.22,and 0.43.Theirinterindividual variability were estimated to be 56.32%,62.24%,33.47%and 42.76%. Theresidual error of effect was 28.54%.
机构地区 南京军区总医院
出处 《药学学报》 CAS CSCD 北大核心 1996年第2期81-85,共5页 Acta Pharmaceutica Sinica
关键词 妊娠高血压 硫酸镁 群体药动学 药物疗法 Hypertension pregnancy induced Magnesium sulfate Population pharmacokinetics Population pharmacedynamics Mathematieal model
  • 相关文献

参考文献3

  • 1王亦流,中国临床药理学杂志,1994年,10卷,87页
  • 2陈刚,中国药理学报,1991年,12卷,222页
  • 3邵志高,中国医院药学杂志,1980年,4卷,439页

同被引文献26

  • 1李珍,陈刚.住院病人茶碱群体药物动力学NONMEM法分析[J].中国药理学报,1994,15(3):267-270. 被引量:6
  • 2芮建中.群体药动学-药效学原理及应用进展[J].国外医学(药学分册),1995,22(5):277-282. 被引量:5
  • 3芮建中,蔡明虹,储小曼,陈 刚.NONMEM法估算中国癫痫患者苯妥英的群体药动学参数[J].药学学报,1995,30(3):172-178. 被引量:14
  • 4芮建中,卓海通,姜国华,陈刚.NONMEM法分析肾移植患者环孢素A的群体药动学[J].药学学报,1995,30(4):241-247. 被引量:8
  • 5Charles M,Thomas S.Expanding clinical applications of population pharmacokinetics modeling[J].Br J Pharmacol,1998,46(4):321.
  • 6Roger J, Alan S, Michael VG. Population pharmacokinetics/pharmacodynamics modeling: parametric and nonparametric methods [J]. Ther Rrug Monit, 2000,22(3) :354.
  • 7Sheiner LB, Rosenberg B, Marathe VV. Estimation of population characteristics of pharmacokinetic parameters from routine clinical data [J]. J Pharmacokinet Biopharm, 1977,5 (5) : 445.
  • 8Vozeh S, Steimer JL, Rowland M, et al. The use of population pharmacokinetics in drug development[ J]. Clin Pharmacokinet, 1996,30(2) : 81.
  • 9Triggs EJ, Charles BG, Contin M, et al. Population pharmacokinetics and pharmacodynamics of oral levodopa in parkinsonian patients [J].Eur J Clin Pharmacol, 1996,51(1) :59.
  • 10Annick R, Pierre M. Application of pharmacokinetic modeling to the routine therapeutic drug monitoring of anticancer drugs[J]. Fundam Clin Pharmacol, 2002.16(4) :253.

引证文献3

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部